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Barry E. Bleske, Pharm.D., Eric W Warren, Pharm.D., Ted L. Rice, M.S., Lori J.  Gilligan, L.V.T., and 
Alan R. Tait, Ph.D. 
We attempted to determine the effect of extreme alkalemia induced by high- 
dose sodium bicarbonate on the vasopressor effects of epinephrine during 
cardiopulmonary resuscitation (CPR) . Subjects in this randomized, blinded 
study performed in a controlled laboratory environment were 12 mongrel 
dogs that had had a previous episode of CPR. Each dog underwent 3 minutes 
of ventricular fibrillation (VF) followed by 7 minutes of closed-chest CPR. 
Animals were assigned to receive either sodium bicarbonate 3 mEq/kg and 
epinephrine 0.1 mg/kg, or normal saline 3 mVkg and epinephrine 0.1 mg/kg. 
The sodium bicarbonate or normal saline was infused over 2 minutes 
beginning at 4 minutes of VF (1 min of CPR) followed by bolus epinephrine. 
Arterial pH in the sodium bicarbonate group was significantly higher at each 
sampling point (7.7 * 0.1 vs 7.29 * 0.06 at 1 min after drug, p<O.OOl). 
However, there were no statistically or clinically significant differences in 
coronary perfusion pressure between the groups at any time: 29 * 13 versus 
32 & 21 mm Hg 1 minute, and 22 * 12 versus 26 f 19 mm Hg 4 minutes after 
epinephrine for sodium bicarbonate and normal saline, respectively ( ~ ~ 0 . 7 ) .  
Increased arterial pH (alkalemia) induced by high-dose sodium bicarbonate 
administration did not improve the vasopressor effects of epinephrine during 
CPR in this canine model. These results suggest the limited value of 
administering sodium bicarbonate during CPR to improve the responsiveness 
to epinephrine. 
(Pharmacotherapy 1995; 15( 5):660-664) 
During cardiopulmonary resuscitation (CPR) , 
the development of systemic acidosis and 
acidemia may alter the efficacy of adrenergic 
The role of these drugs, especially 
epinephrine, during CPR is to increase coronary 
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perfusion pressure and help improve the chances 
for successful resuscitation. Alterations in the 
vasopressor properties of epinephrine may have 
important consequences in this regard. 
Theoretically, the treatment of acidemia may 
improve the vasopressor response to epinephrine, 
since acidotic conditions decrease the vasopressor 
effects of catecholamines. However, a previous 
study showed that a standard dose of sodium 
bicarbonate (1 mEq/kg) does not alter the 
vasopressor effect of epinephrine or improve the 
resuscitation rate.5 That trial only partly 
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evaluated the effect of sodium bicarbonate on the 
vasopressor effects of epinephrine. What was not 
determined was the effect of extreme elevations 
of pH during CPR, which may occur especially 
after administration of large doses of sodium 
bicarbonate. In addition, if any alterations in 
epinephrine’s effect occur, it should be apparent 
with extreme changes in pH. Therefore, we 
assessed the effect of severe alkalemia induced by 
sodium bicarbonate on the vasopressor effects of 
epinephrine during CPR in a canine model. 
Methods 
Animal Preparation 
In this blinded trial, 12 adult mongrel dogs 
(20.1 +- 3.2 kg) that had been resuscitated from 
an episode of cardiac arrest with CPR were 
randomized to one of two treatment groups by a 
random numbers table. All experiments were of 
similar design, involving epinephrine adminis- 
tration and duration (10 min of ventricular 
fibrillation). Animal care and procedures were in 
accord with national and institutional guidelines 
and  approved by the Unit for Laboratory 
Medicine. 
Animals were initially anesthetized with 
pentobarbital 25 mg/kg intravenous injection. 
Anesthesia was maintained with additional doses 
of pentobarbital 5 mg/kg as required. All animals 
were stabilized for at least 30 minutes after 
supplemental doses of pentobarbital before 
beginning the experimental procedure. Each 
animal was secured in a supine position on a 
surgical table with a thermoblanket to maintain a 
body temperature of 37°C. A cuffed endotracheal 
tube was placed, and ventilations controlled with 
an Anesthesia Ventilator (Ohio Medical Products, 
Madison, WI), with a fraction of inspired oxygen 
of 1.0. Initially, the tidal volume was set at  10-15 
ml/kg with a respiratory rate of 12  breaths/ 
minute. Tidal volume and respiratory rate were 
adjusted as necessary to achieve and maintain an 
arterial pH of 7.40 f 0.10 and a partial pressure 
of carbon dioxide (pC02) of 40 +- 10 mm Hg. 
Arterial blood samples were collected in  
heparinized syringes, capped, placed in ice, and 
analyzed using a Radiometer ABL2 (Acid-Base 
Laboratory, Cleveland, OH) within 5 minutes of 
sampling. 
After surgical exposure of a femoral artery and 
vein and jugular vein, catheters were placed. 
Specifically, a 6F pigtailed catheter was placed in 
the aorta for pressure measurements, epinephrine 
administration, and arterial blood gas sampling. 
Additional 6F catheters were placed in the right 
atrium to measure pressure, and in the right 
ventricle to induce ventricular fibrillation (VF) 
and administer sodium bicarbonate. All 
pressures were measured with a Gould P23 
pressure transducer (after calibration) and 
recorded together with a single-lead electro- 
cardiogram by a Gould 8-channel RS 3800 
graphic recorder (Gould Inc., Cleveland, OH). 
Catheter position was determined by evaluating 
the pressure waveforms and was confirmed by 
autopsy if necessary. After catheter placement, 
intravenous heparin 150 U/kg was administered 
to help ensure catheter patency. 
Experimental Protocol 
After obtaining baseline measurements, VF was 
induced by placing a pacing wire in the right 
ventricle and applying a 24-mA, 60-Hz electrical 
current to the ventricle wall. After 3 minutes of 
unassisted ventricular fibrillation (without 
ventilation), CPR was begun using a pneumatic 
chest-compression device (Thumper; Michigan 
Instruments,  Grand Rapids, MI) set at  a 
compression rate of 80/minute with a 
compression duration of 0.5 seconds. Initially, 
the compression force was set to produce a stable 
coronary perfusion pressure gradient (aortic-right 
atrial middiastolic pressure) below 30 mm Hg. 
After every fifth compression, diastole was 
prolonged by 0.5 seconds, and the lungs were 
inflated with an inspiratory pressure setting of 
approximately 15 cm H2O with 100% oxygen. 
After 1 minute of CPR (4 min VF), animals 
were randomized to receive either sodium 
bicarbonate 1 mEq/mL solution (3 mEq/kg) or 
normal saline (3 ml/kg) administered into the 
right ventricle over a 2-minute period, followed 
by intravenous epinephrine 0.1 mg/kg bolus 
administered into the aorta, followed by a 10-ml 
saline flush (6 min VF). Pressure measurements 
and blood gas samples were obtained every 
minute after the end of the sodium bicarbonate 
or normal saline infusion until termination of the 
study (1 0 min VF) . 
Data Analysis 
Pressures were determined using an average of 
five readings of the pressure waveforms per 
pressure measurement by a blinded investigator. 
Statistical comparison of the treatment groups 
was performed by analysis of variance with a 
repeated measures design, and Student’s t test 
with Bonferroni‘s correction where appropriate. 
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Table 1. Arterial Blood Gas Values (n=6) 
Baseline la 2 3 4 
~~ 
Bicarbonate 
PH 7.32k0.04 7.70+0.1b 7.65k0.Zb 7.59+0.19b 7.55kO.22" 
pC02(mmHg) 40k4 .1  48.8k8.2 41.2k6.8 35.8k8.0 34.5k7.8 
HCO< (mEq/L) 20.2 k 2.0 61.0 k 11.2b 48.1 f 21" 34.9 -c 10.4b 30.8 10.3b 
PH 7.33 k 0.04 7.29 f 0.06 7.28 f 0.07 7.25 f 0.08 7.26 k 0.07 
pCOz(mmHg) 41k5 .5  34.5k14.7 34.4k13.9 32.3*13.0 33.2k13.8 
HCO3- (mEq/L) 21 k 2.4 15.5 k 5.3 14.9 k 4.9 13.2 f 4.2 14.2 k S.0 
Baseline = value before ventricular fibrillation; p C 0 ~  = partial pressure of carbon dioxide; HCO3- = 
bicarbonate. 
'Minutes after epinephrine administration 
bp<0.05 compared with normal saline. 
Normal saline 
Data are reported as mean and standard 
deviation. 
Results 
All 12 animals completed the protocol and 
were included in the data analysis. Arterial blood 
gas values for each treatment group throughout 
the study period are shown in Table 1. N o  
significant differences were observed at baseline. 
As expected, however, significant differences in 
pH and bicarbonate concentration were present 
after administration of sodium bicarbonate 
compared with normal saline. All animals in the 
sodium bicarbonate group had pH values above 
7.5, indicating arterial alkalemia. Three of these 
animals had extremely elevated pH values, above 
7.75. In the normal saline group, all animals had 
a pH of 7.4 or below. In four of these animals the 
values were 7.3 or below at the time of peak 
pressure change after epinephrine administration. 
Baseline blood pressures were measured to 
ensure that both groups were comparable. This 
was important,  since each animal had 
experienced a previous episode of VF and CPR of 
similar duration. No significant differences were 
seen in baseline aortic systolic or diastolic 
pressures between the two groups: sodium 
bicarbonate 145 * 45 and 93  * 40 mm Hg; 
normal saline 133 * 37 and 88 f 30 mm Hg 
(p>0.6). 
No significant difference was seen between the 
groups with regard to absolute pressure changes 
(aortic systolic, aortic diastolic, right atrial 
diastolic, coronary perfusion pressure) at any 
time point measured (Table 2). In addition, 
when the data were analyzed by percentage 
change from baseline, there was no significant 
difference between the groups. As shown in 
Figure 1, the two groups, with the exception of 
one animal, appear visually to be identical with 
regard to peak change in coronary perfusion 
pressure. In support  of this, no statistical 
difference occurred in the mean change from 
baseline to peak pressure between the two groups 
(12.5 f 8.9 and 20.1 + /20  mm Hg sodium 
bicarbonate and normal saline, respectively; 
p>0.05). When the one apparent outlier in the 
normal saline group was excluded, the mean 
peak change in pressure between the two groups 
were identical (12.5 f 8.9 and 12.7 f 8.9 mm Hg 
sodium bicarbonate and normal saline, 
respectively; p>0.05). 
Discussion 
Significant arterial alkalemia was induced by 
the administration of sodium bicarbonate 
compared with normal saline. As expected, dogs 
in the normal saline group developed arterial 
acidemia during CPR. Despite the difference in 
arterial blood gas values, no significant difference 
was seen in  the vasopressor response to 
epinephrine between the groups. 
Studies have shown that the vasopressor effect 
of catecholamines may be decreased in  the 
presence of acidosis. l4 Theoretically therefore, 
the treatment of acidosis may improve the 
response to catecholamines. This may have 
important implications especially during CPR, 
when systemic acidosis and arterial and venous 
acidemia occur, and when acidosis is treated by 
ventilation and sodium bicarbonate administration. 
In our earlier study, standard-dose sodium 
bicarbonate 1 mEq/kg did not improve the 
response to epinephrine during CPR,5 which 
suggests that  i t  has no role in treating the 
acidemia that occurs during CPR to increase the 
vasopressor response to epinephrine. However, 
one limitation of that study was that some 
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Table 2 .  Mean Pressure (mm Hg) During CPR (n=6) 
Minutes after Epinephrine Administration 
INF E 1 2 3 4 
Bicarbonate 
AOS 48 f 14.3 48 +- 14.7 60.5 + 18.3 58.1 2 17.3 54.7 f 17.6 51.9 * 13.6 
AOD 20.7 + 8.7 19.3 10.5 32.3 f 13.5 30.3 12.8 25.6 5 12.9 24.4 f 13.2 
CPP 18.4 k 8.1 16.5 k 8.8 28.9 f 12.8 27.3 f 11.4 22.9 k 11.4 22.1 k 12.0 
AOS 42.3 f 7.6 45 k 9.9 73.4 * 15.9 70.3 f 17.7 68.0 k 15.6 65.6 f 12.9 
AOD 14.0+7.0 17.5k9.5 40.4f21.6 37.1k22.1 34.6+20 32.4f19.1 
CPP 11.2 + 8.5 12.7 k 10.8 32.7 f 21.4 29.6 f 21.3 28.2 f 19.8 25.9 19 
INF = start of either sodium bicarbonate or normal saline infusion; E = at the time of epinephrine administration; AOS = 
aortic systolic pressure; AOD = aortic diastolic pressure; CPP = coronary perfusion pressure. 
Normal saline 
animals receiving sodium bicarbonate still had 
arterial acidemia (pH < 7.4), which may have 
potentially altered sodium bicarbonate's influence 
on epinephrine's vasopressor effect. In the 
current study we administered high-dose sodium 
bicarbonate 3 mEq/kg to avoid this limitation 
and to determine the effects of extreme alkalemia 
on the vasopressor response to epinephrine. If 
sodium bicarbonate is to affect the vasopressor 
effect of epinephrine, it should be apparent at  the 
pH achieved in  this study. However, as 
demonstrated, even extreme alkalemia does not 
improve epinephrine's ability to increase 
pressure. This was apparent throughout the 
study, including at the time of epinephrine's peak 
effect that corresponded to the time of the 
highest measured pH. 
The results of this study were similar to those 
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Figure 1. Peak change in coronary perfusion pressure 
(CPP) for each animal. NS = normal saline group; B = 
sodium bicarbonate group; zero base = zero baseline. 
of our previous study evaluating standard-dose 
sodium bicarbonate. In addition, they are similar 
to those of a study in swine that evaluated 
sodium bicarbonate 3 mEq/kg and epinephrine 
0.04 mg/kg.'j However, some important 
differences exist between the studies, including 
the type of CPR performed (open- vs closed- 
chest), and baseline coronary perfusion pressure, 
which was approximately twice as high as that in 
our study (16.5 vs 30 mm Hg). Of the two 
studies, ours probably most represents the 
clinical setting secondary to the type of model 
used (closed chest) and low coronary perfusion 
pressures. Despite the differences, both studies 
have applicable findings and important similar 
results. 
The dose of sodium bicarbonate 3 mEq/kg was 
selected to ensure that all animals developed 
significant arterial alkalemia and was based on 
previous reports.6-8 Sodium bicarbonate was 
infused over 2 minutes to minimize the 
vasodilating effects of a hyperosmolar solution, 
which may decrease coronary perfusion pressure. 
In a previous study in which a similar sodium 
bicarbonate dose was infused over 1 minute, the 
mean decrease in coronary perfusion pressure 
was from 15 to 9 mm H g 8  In our study the 
coronary perfusion pressure decreased by a mean 
of 1.9 f 4 mm Hg after sodium bicarbonate and 
increased by a mean of 3 5 mm Hg after normal 
saline (p=0.12). Therefore, by administering 
sodium bicarbonate over 2 minutes we avoided 
significant transient decreases in  coronary 
perfusion pressure that could have biased the 
results. 
Our findings have to be interpreted with 
caution since the model represents a short period 
of ventricular fibrillation and CPR. I t  is not 
known what might occur with longer periods of 
ventricular fibrillation and CPR at similar doses 
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of sodium bicarbonate and epinephrine.  
Furthermore, our results may have been different 
if the arterial acidemia induced in the normal 
saline group had been more severe (i.e., pH < 
7.0). However, clinically this degree of acidemia 
is rarely seen due to arterial hypocarbia induced 
by aggressive ventilation. Finally, the previous 
episode of ventricular fibrillation and CPR may 
have altered the effects of epinephrine and sodium 
bicarbonate by some unknown mechanism. Our 
findings of increased coronary perfusion pressure 
after epinephrine administration and increased 
arterial pH after sodium bicarbonate adminis- 
tration are consistent with the effects of these 
drugs in animals undergoing only one episode of 
ventricular fibrillation and CPR. 
In conclusion, the significant arterial alkalemia 
induced by high-dose sodium bicarbonate 3 
mEq/kg had no significant effect on the 
vasopressor response to epinephrine compared 
with normal saline in this closed-chest model of 
ventricular fibrillation and CPR in dogs. These 
results, together with findings from other studies, 
suggest that a limited rationale exists for 
administering sodium bicarbonate during 
ventricular fibrillation and CPR to treat arterial 
acidemia in an attempt to improve the vasopressor 
response to epinephrine. 
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